Technical Analysis for PTIX - Protagenic Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.24 | 1.72% | 0.02 |
PTIX closed up 1.72 percent on Wednesday, May 8, 2024, on 12 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 15
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 200 DMA Resistance | Bearish | 1.72% | |
| Narrow Range Bar | Range Contraction | 1.72% | |
| Stochastic Reached Oversold | Weakness | 1.72% | |
| Wide Bands | Range Expansion | 1.72% | |
| Down 3 Days in a Row | Weakness | 1.72% | |
| Oversold Stochastic | Weakness | 1.72% |
| Alert | Time |
|---|---|
| Possible NR7 | about 20 hours ago |
| Fell Below Previous Day's Low | about 23 hours ago |
| Up 1% | about 23 hours ago |
| Possible NR7 | 2 days ago |
| Possible Inside Day | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.32 |
| 52 Week Low | 0.6797 |
| Average Volume | 12,798 |
| 200-Day Moving Average | 1.25 |
| 50-Day Moving Average | 1.37 |
| 20-Day Moving Average | 1.39 |
| 10-Day Moving Average | 1.34 |
| Average True Range | 0.16 |
| RSI (14) | 42.20 |
| ADX | 17.07 |
| +DI | 18.02 |
| -DI | 17.96 |
| Chandelier Exit (Long, 3 ATRs) | 1.32 |
| Chandelier Exit (Short, 3 ATRs) | 1.63 |
| Upper Bollinger Bands | 1.64 |
| Lower Bollinger Band | 1.13 |
| Percent B (%b) | 0.21 |
| BandWidth | 36.26 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0307 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.27 | ||||
| Resistance 3 (R3) | 1.27 | 1.26 | 1.27 | ||
| Resistance 2 (R2) | 1.26 | 1.25 | 1.26 | 1.27 | |
| Resistance 1 (R1) | 1.25 | 1.24 | 1.25 | 1.25 | 1.26 |
| Pivot Point | 1.23 | 1.23 | 1.24 | 1.24 | 1.23 |
| Support 1 (S1) | 1.23 | 1.23 | 1.23 | 1.23 | 1.22 |
| Support 2 (S2) | 1.21 | 1.22 | 1.21 | 1.22 | |
| Support 3 (S3) | 1.20 | 1.21 | 1.21 | ||
| Support 4 (S4) | 1.21 |
